Clinical and economic impact of common multidrug-resistant gram-negative bacilli

被引:485
作者
Giske, Christian G. [1 ]
Monnet, Dominique L. [2 ]
Cars, Otto [3 ]
Carmeli, Yehuda [4 ,5 ]
机构
[1] Karolinska Univ Hosp Solna, Karolinska Inst MTC, SE-17176 Stockholm, Sweden
[2] Statens Serum Inst, Natl Ctr Antimicrobials & Infect Control, DK-2300 Copenhagen, Denmark
[3] Uppsala Univ, Dept Med Sci Clin Bacteriol & Infect Dis, Antibiot Res Unit, Uppsala, Sweden
[4] Beth Israel Deaconess Med Ctr, Div Infect Dis, Boston, MA 02215 USA
[5] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Div Epidemiol, IL-69978 Tel Aviv, Israel
关键词
D O I
10.1128/AAC.01169-07
中图分类号
Q93 [微生物学];
学科分类号
071005 [微生物学]; 100705 [微生物与生化药学];
摘要
引用
收藏
页码:813 / 821
页数:9
相关论文
共 85 条
[1]
Multidrug-resistant Pseudomonas aeruginosa: Risk factors and clinical impact [J].
Aloush, V ;
Navon-Venezia, S ;
Seigman-Igra, Y ;
Cabili, S ;
Carmeli, Y .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (01) :43-48
[2]
Predictors of mortality in patients with bloodstream infection due to ceftazidime-resistant Klebsiella pneumoniae [J].
Anderson, DJ ;
Engemann, JJ ;
Harrell, LJ ;
Carmeli, Y ;
Reller, LB ;
Kaye, KS .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (05) :1715-1720
[3]
[Anonymous], 2002, Infect Control Hosp Epidemiol, V23, P106
[4]
Influx of extended-spectrum β-lactamase producing enterobacteriaceae into the hospital [J].
Ben-Ami, R ;
Schwaber, MJ ;
Navon-Venezia, S ;
Schwartz, D ;
Giladi, M ;
Chmelnitsky, I ;
Leavitt, A ;
Carmeli, Y .
CLINICAL INFECTIOUS DISEASES, 2006, 42 (07) :925-934
[5]
Outcomes evaluation of patients with ESBL- and non-ESBL-producing Escherichia coli and Klebsiella species as defined by CLSI reference methods:: report from the SENTRY Antimicrobial Surveillance Program [J].
Bhavnani, SM ;
Ambrose, PG ;
Craig, WA ;
Dudley, MN ;
Jones, RN .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2006, 54 (03) :231-236
[6]
Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY Antimicrobial Surveillance Program (1997-2002) [J].
Biedenbach, DJ ;
Moet, GJ ;
Jones, RN .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2004, 50 (01) :59-69
[7]
Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa [J].
Bonomo, Robert A. ;
Szabo, Dora .
CLINICAL INFECTIOUS DISEASES, 2006, 43 :S49-S56
[8]
Determining incidence of extended spectrum β-lactamase producing Enterobacteriaceae, vancomycin-resistant Enterococcus faecium and methicillin-resistant Staphylococcus aureus in 38 centres from 17 countries:: the PEARLS study 2001-2002 [J].
Bouchillon, SK ;
Johnson, BM ;
Hoban, DJ ;
Johnson, JL ;
Dowzicky, MJ ;
Wu, DH ;
Visalli, MA ;
Bradford, PA .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2004, 24 (02) :119-124
[9]
Extended-spectrum β-lactamases in the 21st century:: Characterization, epidemiology, and detection of this important resistance threat [J].
Bradford, PA .
CLINICAL MICROBIOLOGY REVIEWS, 2001, 14 (04) :933-951
[10]
OXA β-lactamases in Acinetobacter:: the story so far [J].
Brown, S ;
Amyes, S .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2006, 57 (01) :1-3